Therapeutic Effect of Crizotinib for Rearrangement-negative, High Phosphorylated ALK Patients
Clinical trial NCT05792644 · COMPLETED
Trial details
- NCT number
- NCT05792644
- Sponsor
- Harbin Medical University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2022-05-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.